ACTIVITY NUMBER: MD120
ACTIVITY TITLE: Principles of Fertility Preservation for Reproductive Health Providers
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Society for Reproductive Medicine and the Oncofertility Consortium. The American Society for Reproductive Medicine is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The American Society for Reproductive Medicine designates this enduring material for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Release Date: June 15, 2017
Expiration Date: June 15, 2020
Under Review: August 2022
Estimated Time to Complete Activity: 6 hours
NEEDS ASSESSMENT and IDENTIFICATION OF PRACTICE GAP
The Oncofertility Consortium and ASRM have partnered to establish this online certificate course covering principles of fertility preservation for reproductive health professionals. This course will provide an organized, easily accessible, and evidenced-based review of established and experimental therapies for fertility preservation, patient selection, pre- and post-treatment counseling, as well as ethical considerations in this emerging field.
A recent cross-sectional survey of fellows in Reproductive Endocrinology and Infertility and Gynecologic Oncology identified significant variability in perceived competence in fertility preservation techniques and counselling, with as well as a strong desire for standardized training in this field. In response to these findings, an expert roundtable was convened at the 2014 Oncofertility Consortium Meeting to further elucidate the learning needs of fellows in this topic. Results of the discussion confirmed a practice gap in the competence of graduating fellows to independently counsel and care for fertility preservation patients as well as a dearth of educational resources to assist in this process.
EDUCATIONAL OBJECTIVES
At the conclusion of this educational activity, participants should be able to:
1. Identify patient populations who may benefit from fertility preservation services and summarize currently available established and experimental therapies.
2. Formulate an individualized treatment plan for a given patient who is interested in undergoing fertility preservation.
3. Provide recommendations for the long-term care of the fertility preservation patient.
COURSE OUTLINE
PRE-TREATMENT COUNSELING
- Overview of initial fertility preservation consultation
- Toxicity of chemotherapy and radiation
- Treatment considerations for common conditions
TREATMENT OPTIONS FOR FERTILITY PRESERVATION
- Controlled ovarian stimulation in fertility preservation
- Mature oocyte cryopreservation
- Conservative treatment for gynecologic malignancies
- Use of GnRH agonists for fertility preservation
POST-TREATMENT COUNSELING
- Survivorship
MALE FERTILITY PRESERVATION
- Fertility preservation in male patients
- Sperm cryopreservation methodology
ETHICS OF FERTILITY PRESERVATION
- Fertility Preservation and Reproduction in Patients Facing Gonadotoxic Therapies: An Ethics Committee Opinion
- Posthumous Collection and Use of Reproductive Tissue
TARGET AUDIENCE
This activity is designed to meet the educational needs of physicians and allied health professionals involved in treatment of patients for fertility preservation.
ACGME COMPETENCIES
Medical Knowledge
Patient Care
Professionalism
SUCCESSFUL COMPLETION REQUIREMENTS
Successful completion of this educational activity requires the learner to:
· View a course overview page, containing all CME and disclosure information, including acknowledgement of commercial support and disclosure of unlabeled use, prior to the start of the module.
· Complete a pre-exam prior to each module. Learners should note any pre-exam questions answered incorrectly for clarification during module study.
· Be given the option of downloading a printed syllabus containing the presentation and narrative.
· Participate in the interactive activity with the PowerPoint presentation; this can be stopped, reversed, or advanced as desired.
· After completion of the course, take a 71-question post-exam, with a minimum score of 70 percent correct in two attempts.
· Complete the evaluation survey.
· Print certificate of completion.
DISCLOSURES FOR PLANNERS AND FACULTY
Planners
Divya Kelath Shah, MD Nothing to Disclose
Wendy Vitek, MD Nothing to Disclose
Susan A. Gitlin, PhD Nothing to Disclose
Andrew R. La Barbera, PhD Nothing to Disclose
Richard H. Reindollar, MD Nothing to Disclose
Nancy Bowers, BSN, RN, MPH Nothing to Disclose
Content Developers and Reviewers
Paula Amato, MD Nothing to Disclose
Leslie Appiah, MD Nothing to Disclose
Sara Barton, MD Nothing to Disclose
Jean Benward, MS, MSW Nothing to Disclose
Robert Brannigan, MD AbbVie: Grant/Research
Lynae Brayboy, MD Nothing to Disclose
Paul Brezina, MD, MBA AdvaGenix: Stock ownership
Robert Brzyski, MD, PhD Nothing to Disclose
William Catherino, MD, PhD Consultant: Andrews & Thornton, LLC, Abbvie; Atlee Hall, LLC; Grant/Research: Allergan; Employee (Spouse) EMD Serono
Grace Centola, PhD Consultant: New England Cryogenic Center, Cryos International, Advanced Cell Technologies, Androvia, Reprovantage
Mindy Christianson, MD Nothing to Disclose
Judith Daar, JD Nothing to Disclose
Owen Davis, MD Nothing to Disclose
Daniel Dumesic, MD Nothing to Disclose
Amanda Ellis, RN, BSN Nothing to Disclose
Senait Fisseha, MD, JD Nothing to Disclose
Leslie Francis, PhD, JD Nothing to Disclose
Elena Gates, MD Nothing to Disclose
Elizabeth Ginsburg, MD Serono: Grant/Research
Jeffrey Goldberg, MD Nothing to Disclose
Clarisa Gracia, MD, MSCE Nothing to Disclose
Ashley Haggerty, MD Nothing to Disclose
Edward Illions, MD Nothing to Disclose
Daniel Kaser, MD Nothing to Disclose
Laxmi Kondapalli, MD, MS Nothing to Disclose
Mark Licht, MD Nothing to Disclose
Roger Lobo, MD Nothing to Disclose
Laurence McCullough, PhD Consultant; GlaxoSmithKline
Jennifer Mersereau, MD Nothing to Disclose
Molly Moravek, MD, MPH Nothing to Disclose
John Mulhall, MD Grant/Research: Pfizer, AMS, Vivus; Consultant: AMS, Nexmed, Auxilium
Ceana Nezhat, MD Consultant: SurgiQuest, Plasma Surgical, Karl Storz Endoscopy
Randall Odem, MD Nothing to Disclose
Lauri Pasch, PhD Nothing to Disclose
Mary Ellen Pavone, MD, MSc Nothing to Disclose
Samantha Pfeifer, MD Consultant: Best Doctors, Inc.
Margareta Pisarska, MD Consultant: Babycenter.com; Grant/Research: NIH, ASRM
Steven Ralston, MD Board Member: Planned Parenthood; Chair, ACOG Committee on Ethics
John Robertson, JD Nothing to Disclose
Mitchell Rosen, MD Ferring: Other
Brooke Rossi, MD Nothing to Disclose
Jay Sandlow, MD Nothing to Disclose
Mark Sauer, MD Nothing to Disclose
Irene Souter, MD Nothing to Disclose
Julie Rios Sroga, MD Nothing to Disclose
Kristin Smith, BS Nothing to Disclose
Monique Spillman, MD Nothing to Disclose
Andrea Stein, MD Nothing to Disclose
Bonnie Steinbock, PhD Nothing to Disclose
Judy Stern, PhD Nothing to Disclose
Irene Su, MD Nothing to Disclose
Cigdem Tanrikut, MD Nothing to Disclose
Michael Thomas, MD Grant/Research: Medicine 360; Grant/Research: EvoFem
Kim Thornton, MD Nothing to Disclose
Michael Vernon, PhD Nothing to Disclose
Eric Widra, MD Consultant: Natera, Counsyl
Bruce Wilder, MD, MPH, JD Nothing to Disclose
It is the policy of the ASRM to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/authors participating in this activity were required to disclose any relationships they may have with commercial entities whose products or services are used to treat patients so that participants may evaluate the objectivity of the presentations. The content and views presented in this activity are those of the faculty/authors and do not necessarily reflect those of the ASRM. Any discussion of off-label, experimental, or investigational use of drugs or devices will also be disclosed. The disclosure statements were reviewed by the Subcommittee for Standards of Commercial Support of the CME Committee of ASRM and any perceived conflicts of interest were resolved in accordance with the policies of the ACCME.
STATEMENT OF SUPPORT
No commercial support has been provided for this activity.